1. Home
  2. GRNQ vs CYCN Comparison

GRNQ vs CYCN Comparison

Compare GRNQ & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • CYCN
  • Stock Information
  • Founded
  • GRNQ 2013
  • CYCN 2018
  • Country
  • GRNQ Malaysia
  • CYCN United States
  • Employees
  • GRNQ N/A
  • CYCN N/A
  • Industry
  • GRNQ EDP Services
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • CYCN Health Care
  • Exchange
  • GRNQ Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • GRNQ 8.9M
  • CYCN 8.4M
  • IPO Year
  • GRNQ 2018
  • CYCN N/A
  • Fundamental
  • Price
  • GRNQ $1.09
  • CYCN $3.10
  • Analyst Decision
  • GRNQ
  • CYCN
  • Analyst Count
  • GRNQ 0
  • CYCN 0
  • Target Price
  • GRNQ N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • GRNQ 57.0K
  • CYCN 5.8M
  • Earning Date
  • GRNQ 03-27-2025
  • CYCN 03-04-2025
  • Dividend Yield
  • GRNQ N/A
  • CYCN N/A
  • EPS Growth
  • GRNQ N/A
  • CYCN N/A
  • EPS
  • GRNQ N/A
  • CYCN N/A
  • Revenue
  • GRNQ $2,727,344.00
  • CYCN $194,000.00
  • Revenue This Year
  • GRNQ N/A
  • CYCN N/A
  • Revenue Next Year
  • GRNQ N/A
  • CYCN N/A
  • P/E Ratio
  • GRNQ N/A
  • CYCN N/A
  • Revenue Growth
  • GRNQ N/A
  • CYCN N/A
  • 52 Week Low
  • GRNQ $0.80
  • CYCN $1.27
  • 52 Week High
  • GRNQ $2.24
  • CYCN $9.47
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 51.58
  • CYCN 45.42
  • Support Level
  • GRNQ $0.97
  • CYCN $2.81
  • Resistance Level
  • GRNQ $1.13
  • CYCN $4.80
  • Average True Range (ATR)
  • GRNQ 0.06
  • CYCN 0.74
  • MACD
  • GRNQ 0.01
  • CYCN -0.08
  • Stochastic Oscillator
  • GRNQ 80.37
  • CYCN 17.72

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: